Quantcast

Latest ViaCyte Inc. Stories

2015-05-14 08:37:08

SAN DIEGO, May 14, 2015 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company with the first stem cell-derived islet replacement therapy for the treatment of diabetes

2015-05-11 08:32:42

SAN DIEGO, May 11, 2015 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company with the first pluripotent stem cell-derived islet replacement therapy for the treatment

2015-03-17 08:32:30

SAN DIEGO, March 17, 2015 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company with the first stem cell-derived islet replacement therapy for the treatment of diabetes

2015-03-03 08:37:08

SAN DIEGO and BETHESDA, Md., March 3, 2015 /PRNewswire/-- ViaCyte, Inc., a privately-held regenerative medicine company with the first stem cell-derived islet replacement therapy for

2014-12-22 08:28:15

SAN DIEGO and SAN FRANCISCO, Dec.

2014-12-18 08:28:46

Induced immune tolerance may reduce the need for long-term immunosuppression SAN DIEGO, Dec. 18, 2014 /PRNewswire/ -- ViaCyte, Inc.


Word of the Day
chomage
  • Stoppage; cessation (of labor).
  • A standing still or idling (of mills, factories, etc.).
The word chomage comes into English from French.]
Related